Y, C., JS, H., HT, Y., YC, S., CC, W., JS, C., . . . CP, L. (2014). A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. Cancer chemotherapy and pharmacology, 73(4), 799. https://doi.org/10.1007/s00280-014-2407-y
Chicago Style (17th ed.) CitationY, Chao, et al. "A Multicenter Phase II Study of Biweekly Capecitabine in Combination with Oxaliplatin as First-line Chemotherapy in Patients with Locally Advanced or Metastatic Gastric Cancer." Cancer Chemotherapy and Pharmacology 73, no. 4 (2014): 799. https://doi.org/10.1007/s00280-014-2407-y.
MLA (9th ed.) CitationY, Chao, et al. "A Multicenter Phase II Study of Biweekly Capecitabine in Combination with Oxaliplatin as First-line Chemotherapy in Patients with Locally Advanced or Metastatic Gastric Cancer." Cancer Chemotherapy and Pharmacology, vol. 73, no. 4, 2014, p. 799, https://doi.org/10.1007/s00280-014-2407-y.